Serial audiometry in a clinical trial of AIED treatment

Otology and Neurotology

Volumn 26, Issue 5, 2005, Pages 908-917

  Niparko, John K ^a   Wang, Nae Yuh ^b   Rauch, Steven D ^b   Russell, Gregory B ^b   Espeland, Mark A ^b   Pierce, June J ^b   Bowditch, Stephen ^b   Masuda, Ann ^b   Gulya, A Julianna ^b   Gantz, Bruce J ^b   Hughes, Gordon B ^b   Brookhouser, Patrick E ^b   Hannley, Maureen T ^b   Telian, Steven A ^b   Harris, Jeffrey P ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE; PLACEBO; PREDNISONE;

ACCURACY; ADULT; AGED; ARTICLE; AUDIOMETRY; AUTOIMMUNE DISEASE; AUTOIMMUNE INNER EAR DISEASE; CLINICAL TRIAL; COCHLEA; FEMALE; HUMAN; IDIOPATHIC DISEASE; INNER EAR DISEASE; MAJOR CLINICAL STUDY; MALE; PERCEPTION DEAFNESS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SERIAL AUDIOMETRY; SPEECH AUDIOMETRY; SPEECH INTELLIGIBILITY; STATISTICAL SIGNIFICANCE; STEROID THERAPY;

ADOLESCENT; ADULT; AGED; AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; AUDITORY THRESHOLD; AUTOIMMUNE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; LABYRINTH DISEASES; MALE; MIDDLE AGED; PREDNISONE; SPEECH PERCEPTION; TREATMENT OUTCOME;

EID: 24944533928     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000185081.28598.5c     Document Type: Article

References (15)

1. Harris JP, Weisman MH, Derebery JM, et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 2003;290:1875-83.
2. Harris JP, Heydt J, Keithley EM, Chen MC. Immunopathology of the inner ear: an update. Ann N Y Acad Sci 1997;830:166-78.
3. Harris JP. Experimental autoimmune sensorineural hearing loss. Laryngoscope 1987;97:63-76.
4. Lehnhardt E. Sudden hearing disorders occurring simultaneously or successively on both sides. Z Laryngol Rhinol Otol 1958;37:1-16.
5. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
6. Cucullo L, Hallene K, Dini G, et al. Glycerophosphoinositol and dexamethasone improve transendothelial electrical resistance in an in vitro study of the blood-brain barrier Brain Res 2004;997:147-51.
7. Dietrich JB. Endothelial cells of the blood-brain barrier: a target for glucocorticoids and estrogens? Front Biosci 2004;9:684-93.
8. Lee JH, Marcus DC. Nongenomic effects of corticosteroids on ion transport by stria vascularis. Audiol Neurootol 2002;7:100-6.
9. Moscicki RA, San Martin JE, Quintero CH, et al. Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment. JAMA 1994;272:611-6.
10. Yeom K, Gray J, Nair TS, et al. Antibodies to HSP-70 in normal donors and autoimmune hearing loss patients. Laryngoscope 2003;113:1770-6.
11. Hirose K, Wener MH, Duckert LG. Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 1999;109:1749-54.
12. Barrs D. Neurotologic issues: autoimmune inner ear disease. Semin Neurol 2003;23:315-24.
13. Browner W, Newman T, Cummings S, Hulley S. Estimates of sample size. In: Hulley S, Cummings S, eds. Designing Clinical Research: An Epidemiologic Approach. Baltimore, MD: Williams & Wilkins, 1988, 128-143.
14. Penrod J. Speech discrimination testing. In: Katz J, ed. Handbook of Clinical Audiology, 4th ed. Baltimore, MD: Williams & Wilkins, 1994, 159-160.
15. French NR, Steinberg JC. Factors governing the intelligibility of speech sounds. J Acoust Soc Am 1947;19:90-119.